166 related articles for article (PubMed ID: 29284359)
1. Rare incidence of tumor lysis syndrome in metastatic prostate cancer following treatment with docetaxel.
Bhardwaj S; Varma S
J Oncol Pharm Pract; 2018 Mar; 24(2):153-155. PubMed ID: 29284359
[TBL] [Abstract][Full Text] [Related]
2. Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer.
Sorscher SM
Cancer Chemother Pharmacol; 2004 Aug; 54(2):191-2. PubMed ID: 15148627
[TBL] [Abstract][Full Text] [Related]
3. Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer.
Wright JL; Lin DW; Dewan P; Montgomery RB
Int J Urol; 2005 Nov; 12(11):1012-3. PubMed ID: 16351664
[TBL] [Abstract][Full Text] [Related]
4. Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer.
Ajzensztejn D; Hegde VS; Lee SM
J Clin Oncol; 2006 May; 24(15):2389-91. PubMed ID: 16710040
[No Abstract] [Full Text] [Related]
5. Treatment-naïve spontaneous tumor lysis syndrome in metastatic prostate adenocarcinoma: An unusual suspect.
Ignaszewski M; Kohlitz P
Am J Emerg Med; 2017 Sep; 35(9):1384.e1-1384.e2. PubMed ID: 28587951
[TBL] [Abstract][Full Text] [Related]
6. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature.
Taira F; Horimoto Y; Saito M
Breast Cancer; 2015 Nov; 22(6):664-8. PubMed ID: 23420376
[TBL] [Abstract][Full Text] [Related]
7. Real-world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer.
Rulach RJ; McKay S; Neilson S; White L; Wallace J; Carruthers R; Lamb C; Cascales A; Marashi H; Glen H; Venugopal B; Sadoyze A; Sidek N; Russell JM; Alhasso A; Dodds D; Laskey J; Jones RJ; MacLeod N
BJU Int; 2018 Feb; 121(2):268-274. PubMed ID: 28940952
[TBL] [Abstract][Full Text] [Related]
8. A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel.
Ross RW; Beer TM; Jacobus S; Bubley GJ; Taplin ME; Ryan CW; Huang J; Oh WK;
Cancer; 2008 Feb; 112(3):521-6. PubMed ID: 18085595
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer.
Armstrong AJ; George DJ
Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):108-16. PubMed ID: 20066005
[TBL] [Abstract][Full Text] [Related]
10. Tumor lysis syndrome and metastatic melanoma.
Meeks MW; Hammami MB; Robbins KJ; Cheng KL; Lionberger JM
Med Oncol; 2016 Dec; 33(12):134. PubMed ID: 27807723
[TBL] [Abstract][Full Text] [Related]
11. Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer.
Lin CJ; Hsieh RK; Lim KH; Chen HH; Cheng YC; Wu CJ
South Med J; 2007 Sep; 100(9):916-7. PubMed ID: 17902299
[No Abstract] [Full Text] [Related]
12. Tumour lysis syndrome in haematological malignancies.
van der Hoven B; Thunnissen PL; Sizoo W
Neth J Med; 1992 Feb; 40(1-2):31-5. PubMed ID: 1579184
[TBL] [Abstract][Full Text] [Related]
13. Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial.
Kellokumpu-Lehtinen PL; Hjälm-Eriksson M; Thellenberg-Karlsson C; Åström L; Franzen L; Marttila T; Seke M; Taalikka M; Ginman C;
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):303-7. PubMed ID: 22546837
[TBL] [Abstract][Full Text] [Related]
14. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
15. Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Tucci M; Bertaglia V; Vignani F; Buttigliero C; Fiori C; Porpiglia F; Scagliotti GV; Di Maio M
Eur Urol; 2016 Apr; 69(4):563-573. PubMed ID: 26422676
[TBL] [Abstract][Full Text] [Related]
16. Tumor lysis syndrome following hemi-body irradiation for metastatic breast cancer.
Rostom AY; El-Hussainy G; Kandil A; Allam A
Ann Oncol; 2000 Oct; 11(10):1349-51. PubMed ID: 11106126
[TBL] [Abstract][Full Text] [Related]
17. Tumor lysis syndrome in small cell lung cancer.
Kallab AM; Jillella AP
Med Oncol; 2001; 18(2):149-51. PubMed ID: 11778761
[TBL] [Abstract][Full Text] [Related]
18. Cabazitaxel for metastatic hormone-relapsed prostate cancer treated with docetaxel.
Lovett R; Kelly V; Goodall M; Adler AI
Lancet Oncol; 2016 Jul; 17(7):872-873. PubMed ID: 27234583
[No Abstract] [Full Text] [Related]
19. Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy.
Isaacsson Velho P; Eisenberger MA
Oncology (Williston Park); 2018 May; 32(5):223-6. PubMed ID: 29847851
[No Abstract] [Full Text] [Related]
20. Tumor lysis syndrome in anti-androgen-treated metastatic prostate cancer.
Mazzoni S
Int Urol Nephrol; 2016 Nov; 48(11):1837-1838. PubMed ID: 27417133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
